2019
DOI: 10.1080/23328940.2019.1567247
|View full text |Cite
|
Sign up to set email alerts
|

The interaction between neurokinin-1 receptors and cyclooxygenase-2 in fever genesis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 5 publications
0
2
0
Order By: Relevance
“…Specifically, the truncated form lacks 96 amino acids in its C-terminal site, due to the presence of a premature stop codon before exon-5. The two types of NK1R are also different in term of SP affinity, the full-length form being ten times more affine to SP, despite the fact that the SP binding domain is similar in both isoforms [7,11,13]. In fact, nanomolar concentrations of SP are sufficient to activate the full length NK1R, whereas micromolar concentrations of SP are required to activate truncated-NK1R [13].…”
Section: Nk1r Structurementioning
confidence: 99%
See 1 more Smart Citation
“…Specifically, the truncated form lacks 96 amino acids in its C-terminal site, due to the presence of a premature stop codon before exon-5. The two types of NK1R are also different in term of SP affinity, the full-length form being ten times more affine to SP, despite the fact that the SP binding domain is similar in both isoforms [7,11,13]. In fact, nanomolar concentrations of SP are sufficient to activate the full length NK1R, whereas micromolar concentrations of SP are required to activate truncated-NK1R [13].…”
Section: Nk1r Structurementioning
confidence: 99%
“…The NK1R is widely expressed in the eye, including ocular (corneal and retinal cells) and non-ocular cells (endothelial cells, leukocytes, and neurons) [3,7].…”
Section: Introduction 1the Tachykinin Peptide Family and Its Receptorsmentioning
confidence: 99%